We are excited to announce the release of our new company introduction video, now available on our media page. This video provides an insightful look into our mission, values, and our role as a leading manufacturer of vaccines in the Kingdom of Saudi Arabia. Watch the video to learn more about our journey, our commitment...
Under the esteemed patronage of His Excellency the Irish Ambassador and representatives of the Irish government, a significant milestone in the biotechnology and vaccine manufacturing sector was achieved today at the Irish Embassy. A project management agreement was officially signed between VACCINE INDUSTRIAL COMPANY (VIC) the largest vaccine manufacturer in the Middle East, Modon-Sudair, and...
Saudi Authority for Industrial Cities and Technology Zones (MODON) has signed a SR500m ($133m) investment agreement with the Vaccine Industrial Company (Vaccine) to set up a joint venture factory in Sudair City to strengthen the pharmaceutical security system and localise the manufacturing of vaccines and vital medicines in the Kingdom. This agreement comes in line...
SAR500m facility in Sudair City To produce vaccines and medicines Pharma worth $19.8bn by 2032 Saudi Arabia is planning to invest SAR500 million ($133 million) in a factory to boost local vaccine and medicine manufacturing capacity as the kingdom seeks to become a regional centre for biotechnology. Saudi Authority for Industrial Cities and Technology Zones,...
Vaccine industrials company and Saudi authority for industrial cities and technology zone (modon) have signed land allocation agreement with an area of 42 thousand and square meters to establish vaccines manufacturing facility in sudair industrial city, Saudi Arabia.
President of Research, Development and Innovation Authority (RDIA) meeting with VCRDI team to discuss the authority roles in supporting RDI system in Saudi Arabia and to discuss ways to facilitate technology transfer and vaccine development localization efforts.
VCRDI and Baylor College of Medicine (BCM) have signed Academic and R&D agreement for vaccine development. VCRDI and BCM have singed a training agreement to train VCRDI scientists in vaccine development, including scale-up process development, quality control testing, formulation technology, and regulatory documentation. The Training Program will be conducted at BCM’s facilities (Center for Vaccine...
